Isabel Fragata1, Teresa Morais1, Rita Silva2, Ana Paiva Nunes3, Petra Loureiro4, José Diogo Martins4, Jaime Pamplona1, Rui Carvalho1, Mariana Baptista1, João Reis1. 1. Neuroradiology Department, Centro Hospitalar Universitário Lisboa Central, Lisboa, Portugal. 2. Pediatric Neurology Department, Centro Hospitalar Universitário Lisboa Central, Lisboa, Portugal. 3. Stroke Unit, Centro Hospitalar Universitário Lisboa Central, Lisboa, Portugal. 4. Pediatric Cardiology Department, Centro Hospitalar Universitário Lisboa Central, Lisboa, Portugal.
Abstract
INTRODUCTION: Mechanical thrombectomy is standard treatment for large vessel occlusion (LVO) in adults. There are no randomized controlled trials for the pediatric population. We report our single-center experience with thrombectomy of LVO in a series of pediatric patients, and perform a review of the literature. METHODS: Retrospective review of consecutive pediatric thrombectomy cases between 2011 and 2018. Demographic variables, imaging data, technical aspects and clinical outcome were recorded. RESULTS: In a period of 7 years, 7 children were treated for LVO at our center. Median age was 13 (2-17), and median Ped-NIHSS was 15 (3-24), and the median ASPECTS was 8 (2-10). Five patients had cardiac disease, and 2 of them were under external cardiac assistance. Median time from onset of symptoms to beginning of treatment was 7h06m (2h58m-21h38m). Five patients had middle cerebral artery occlusions. Thrombectomy was performed using a stentriever in 3 patients, aspiration in 3 patients, and combined technique in 1 patient. Six patients had good recanalization (TICI 2 b/3). There were no immediate periprocedural complications. At 3 months, 4 patients (57%) were independent (mRS score <3). Two patients died, one after haemorrhagic transformation of an extensive MCA infarct, and one due to extensive brainstem ischemia in the setting of varicella vasculitis. DISCUSSION: Selected pediatric patients with LVO may be treated with mechanical thrombectomy safely. In patients under external cardiac assistance and under anticoagulation, thrombectomy is the only alternative for treatment of LVO. A multidisciplinary approach in specialized pediatric stroke centers with trained neurointerventionalists are essential for good results.
INTRODUCTION: Mechanical thrombectomy is standard treatment for large vessel occlusion (LVO) in adults. There are no randomized controlled trials for the pediatric population. We report our single-center experience with thrombectomy of LVO in a series of pediatric patients, and perform a review of the literature. METHODS: Retrospective review of consecutive pediatric thrombectomy cases between 2011 and 2018. Demographic variables, imaging data, technical aspects and clinical outcome were recorded. RESULTS: In a period of 7 years, 7 children were treated for LVO at our center. Median age was 13 (2-17), and median Ped-NIHSS was 15 (3-24), and the median ASPECTS was 8 (2-10). Five patients had cardiac disease, and 2 of them were under external cardiac assistance. Median time from onset of symptoms to beginning of treatment was 7h06m (2h58m-21h38m). Five patients had middle cerebral artery occlusions. Thrombectomy was performed using a stentriever in 3 patients, aspiration in 3 patients, and combined technique in 1 patient. Six patients had good recanalization (TICI 2 b/3). There were no immediate periprocedural complications. At 3 months, 4 patients (57%) were independent (mRS score <3). Two patients died, one after haemorrhagic transformation of an extensive MCA infarct, and one due to extensive brainstem ischemia in the setting of varicella vasculitis. DISCUSSION: Selected pediatric patients with LVO may be treated with mechanical thrombectomy safely. In patients under external cardiac assistance and under anticoagulation, thrombectomy is the only alternative for treatment of LVO. A multidisciplinary approach in specialized pediatric stroke centers with trained neurointerventionalists are essential for good results.
Authors: Mary In-Ping Huang Cobb; Avra S Laarakker; L Fernando Gonzalez; Tony P Smith; Erik F Hauck; Ali R Zomorodi Journal: Stroke Date: 2017-06-08 Impact factor: 7.914
Authors: Raul G Nogueira; Ashutosh P Jadhav; Diogo C Haussen; Alain Bonafe; Ronald F Budzik; Parita Bhuva; Dileep R Yavagal; Marc Ribo; Christophe Cognard; Ricardo A Hanel; Cathy A Sila; Ameer E Hassan; Monica Millan; Elad I Levy; Peter Mitchell; Michael Chen; Joey D English; Qaisar A Shah; Frank L Silver; Vitor M Pereira; Brijesh P Mehta; Blaise W Baxter; Michael G Abraham; Pedro Cardona; Erol Veznedaroglu; Frank R Hellinger; Lei Feng; Jawad F Kirmani; Demetrius K Lopes; Brian T Jankowitz; Michael R Frankel; Vincent Costalat; Nirav A Vora; Albert J Yoo; Amer M Malik; Anthony J Furlan; Marta Rubiera; Amin Aghaebrahim; Jean-Marc Olivot; Wondwossen G Tekle; Ryan Shields; Todd Graves; Roger J Lewis; Wade S Smith; David S Liebeskind; Jeffrey L Saver; Tudor G Jovin Journal: N Engl J Med Date: 2017-11-11 Impact factor: 91.245
Authors: Hazem Shoirah; Hussain Shallwani; Adnan H Siddiqui; Elad I Levy; Cynthia L Kenmuir; Tudor G Jovin; Michael R Levitt; Louis J Kim; Julius Griauzde; Aditya S Pandey; Joseph J Gemmete; Todd Abruzzo; Adam S Arthur; Lucas Elijovich; Daniel Hoit; Ahmed Cheema; Amin Aghaebrahim; Eric Sauvageau; Ricardo Hanel; Andrew J Ringer; Fábio A Nascimento; Peter Kan; J Mocco Journal: J Neurointerv Surg Date: 2019-03-06 Impact factor: 5.836
Authors: Anne L Gordon; Vicki Anderson; Michael Ditchfield; Lee Coleman; Mark T Mackay; Mardee Greenham; Rod W Hunt; Paul Monagle Journal: Int J Stroke Date: 2015-04-28 Impact factor: 5.266
Authors: Ryan J Felling; Lisa R Sun; Emily C Maxwell; Neil Goldenberg; Timothy Bernard Journal: Blood Cells Mol Dis Date: 2017-03-07 Impact factor: 3.039
Authors: Susana Sainz de la Maza; Alicia De Felipe; Maria Consuelo Matute; Eduardo Fandiño; José Carlos Méndez; Pablo Morillo; Jaime Masjuan Journal: J Child Neurol Date: 2013-11-21 Impact factor: 1.987
Authors: Lucia Gerstl; M Olivieri; F Heinen; C Bidlingmaier; A S Schroeder; K Reiter; F Hoffmann; K Kurnik; T Liebig; C G Trumm; N A Haas; A Jakob; I Borggraefe Journal: Nervenarzt Date: 2022-01-24 Impact factor: 1.297